Novo Nordisk Faces Two Realities: EU Approvals Bolster Pipeline as Canadian Patent Loss and Pricing
Novo Nordisk secures EU backing for oral and high-dose Wegovy but faces Canadian patent loss on Ozempic, triggering…
From Chatbots to Chemists: Novo Nordisk’s Wegovy Pill Surges as Canadian Generics Undercut Ozempic
Novo Nordisk’s Wegovy leads weight-loss drug search results on AI chatbots, but generic semaglutide enters Canadian pharmacies at…
Novo Nordisk Battles Pricing Storm on Two Fronts as Canadian Generics and US Policy Converge
US TrumpRx portal adds 600+ generic drugs, Canada approves first Ozempic generics, pressuring Novo Nordisk stock (down 15%…
Novo Nordisk Balances Canadian Price Pressure With Sickle Cell Advance and Oral Pill Triumph
Novo Nordisk rebounds 31% on obesity data, but Canada generic semaglutide threatens pricing. Wegovy oral pill sales surge…
Generics, Q1 Results, and a Pipeline Showcase
Novo Nordisk enters a critical period with Q1 earnings, a Canadian Ozempic generic launch, and obesity conference data,…
Teen Pill Success Meets Canadian Generic Shock
Novo Nordisk celebrates positive trial results for oral semaglutide in teens while facing first generic Ozempic competition in…
Novo Nordisk’s Hemophilia Breakthrough Fails to Distract From Canadian Generic Blow
Novo Nordisk’s stock slides 41% as Canada approves first generic Ozempic, while promising hemophilia data fails to lift…
Canadian Generic Launch and Q1 Results Loom
Health Canada authorizes Dr. Reddy’s biosimilar semaglutide, threatening Novo Nordisk’s Ozempic revenue as share buyback reaches 3.44 billion…
Novo Nordisk’s Teen Pill Breakthrough and Canadian Generic Blow Arrive in the Same Week
Novo Nordisk faces a historic Ozempic generic in Canada while scoring a first-in-class oral GLP-1 win for teens,…
Former CFL player Bailey Feltmate signs with Oslo Vikings in Norway
Photo: Michael Scraper/3DownNation. All rights reserved. Former CFL fullback Bailey Feltmate is heading to Norway to play for…